What D7286 means

D7286 covers a biopsy of oral tissue — soft. "D" is dental, "72" is this oral surgery group, and "86" is this soft-tissue biopsy. A biopsy is the removal of a tissue sample for laboratory (pathology) examination — to diagnose a condition by analyzing the tissue under a microscope. D7286 is specifically for a biopsy of soft oral tissue — the soft tissues of the mouth (gum/gingiva, oral mucosa, lip, tongue, floor of the mouth, palate soft tissue, and other soft tissues), as opposed to hard tissue (bone/tooth, which is D7285). So when there's an abnormality of the soft tissues — e.g., a suspicious lesion, a persistent sore or ulcer, an abnormal patch (white or red), a growth/lump, or another soft-tissue abnormality — and a sample needs to be taken for diagnosis, D7286 reports the soft-tissue biopsy. The sample is sent to a pathology lab, which examines it and provides a diagnosis.

So it's surgically removing a sample of soft oral tissue for pathology examination, to diagnose a soft-tissue abnormality.

A soft-tissue biopsy is a key diagnostic procedure in the mouth — used to diagnose oral lesions, including (importantly) to evaluate for oral cancer or precancer (a persistent suspicious lesion may be biopsied to rule out or diagnose dysplasia or carcinoma). The ADA's description notes it's for the surgical removal of an architecturally intact specimen only — i.e., obtaining an intact tissue sample (the pathology lab's analysis is separate). It's typically an incisional biopsy (removing a portion of the lesion for diagnosis), though for small lesions an excisional biopsy (removing the whole lesion) might be done (sometimes coded differently). D7286 is not used at the same time as codes for apicoectomy/periradicular curettage. Coverage may involve dental and/or medical insurance (especially if malignancy is suspected, with possible cross-coding); a pathology report is part of the documentation.

When it's typically used

D7286 is reported for a biopsy of soft oral tissue — surgically removing a sample of soft tissue (gum, mucosa, lip, tongue, etc.) for laboratory (pathology) examination — to diagnose an abnormality (e.g., a suspicious lesion, persistent sore, abnormal patch, or growth). It's for the surgical removal of an intact specimen, typically an incisional biopsy, distinct from a hard-tissue biopsy (D7285) and cytology sampling (D7287/D7288).

How much does D7286 cost?

A soft-tissue biopsy is a moderate fee, often roughly 200 to 500 USD depending on region and the complexity — for the surgical removal of the soft-tissue specimen. The pathology lab's examination of the sample is a separate cost (the lab fee). The fee reflects the surgical procedure of obtaining the soft-tissue specimen (typically done under local anesthesia).

Is D7286 covered by insurance?

Covered under oral surgery/diagnostic benefits, though some cases (especially if malignancy is suspected) may involve submission to medical insurance first (with cross-coding to a medical CPT code, e.g., for the specific site). Documentation includes the clinical findings and a copy of the pathology report. D7286 is for the surgical removal of the specimen only (the lab analysis is separate). It's distinct from a hard-tissue biopsy (D7285) and cytology codes (D7287/D7288). Verifying coverage (dental vs medical) helps.

What a soft-tissue biopsy is

A soft-tissue biopsy samples soft oral tissue for diagnosis, and understanding it clarifies this procedure.

A biopsy is a diagnostic procedure — removing a tissue sample and sending it to a pathology lab for examination (under a microscope) to diagnose a condition. A soft-tissue biopsy (D7286) is specifically a biopsy of the soft oral tissues — the gum (gingiva), oral mucosa (the lining of the mouth, cheeks, etc.), lip, tongue, floor of the mouth, soft palate tissue, and other soft tissues — as opposed to the hard tissues (bone/tooth, which is D7285). So when there's an abnormality of the soft tissues — a suspicious lesion, a persistent sore, an abnormal-looking patch or growth — a soft-tissue biopsy removes a sample of it for diagnosis. The sample is sent to an oral pathologist (or pathology lab), who examines it and determines what it is (providing a diagnosis).

The purpose is diagnostic — to find out the nature of a soft-tissue abnormality. The ADA description specifies it's for the surgical removal of an architecturally intact specimen — i.e., obtaining an intact piece of tissue (preserving its structure) for the pathologist to examine (which is important for an accurate diagnosis). So D7286 covers the surgical removal of the soft-tissue specimen. The diagnosis (from the pathology lab) then guides treatment. The dentist/oral surgeon performs the soft-tissue biopsy to obtain the sample. For patients, understanding what a soft-tissue biopsy is — removing a sample of soft oral tissue for pathology examination to diagnose an abnormality — clarifies this procedure. It samples soft tissue for diagnosis. The surgeon performs it. Understanding this helps patients see that a soft-tissue biopsy (D7286) is a diagnostic procedure — surgically removing an intact sample of soft oral tissue (gum, mucosa, lip, tongue, etc.) and sending it to a pathology lab for examination — to diagnose an abnormality of the soft tissues (e.g., a suspicious lesion, persistent sore, abnormal patch, or growth), with the pathologist's analysis providing the diagnosis that guides treatment, the biopsy obtaining the tissue for diagnosis.

Diagnosing oral lesions and screening for cancer

A soft-tissue biopsy diagnoses oral lesions, including evaluating for cancer, and understanding this clarifies its importance.

A key role of the soft-tissue biopsy is diagnosing oral lesions — including the critically important task of evaluating for oral cancer or precancer. Various soft-tissue abnormalities can appear in the mouth: persistent sores or ulcers (that don't heal), abnormal patches (white patches — leukoplakia; red patches — erythroplakia; or mixed), lumps or growths, or other lesions. Many such lesions are benign, but some can be precancerous (showing dysplasia — abnormal cell changes) or cancerous (oral squamous cell carcinoma or other malignancies). The appearance alone often can't definitively distinguish these — a biopsy is needed to know for certain. So when a suspicious or persistent soft-tissue lesion is found, a biopsy is done to diagnose it — to rule out or identify dysplasia or carcinoma (cancer).

This makes the soft-tissue biopsy a crucial tool for the early detection of oral cancer — a persistent or suspicious lesion biopsied can reveal cancer at an early, more treatable stage (or precancerous changes that can be managed before they become cancer), or provide reassurance if benign. Early diagnosis significantly improves outcomes for oral cancer. So the biopsy plays a vital role in oral cancer detection (and in diagnosing oral lesions generally). For example, a persistent red or white patch, or a non-healing ulcer, would warrant a biopsy to determine its nature. The dentist/oral surgeon biopsies suspicious lesions to diagnose them. For patients, understanding that a soft-tissue biopsy diagnoses oral lesions — including the important role of evaluating for cancer — clarifies its importance. It can detect (or rule out) cancer. The surgeon biopsies suspicious lesions. Understanding this helps patients see that a soft-tissue biopsy is a key tool for diagnosing oral lesions — including the critically important evaluation for oral cancer or precancer — since suspicious lesions (persistent sores, abnormal white or red patches, growths) often can't be definitively diagnosed by appearance alone, so a biopsy determines whether they're benign, precancerous (dysplasia), or cancerous (carcinoma), enabling early detection and treatment of oral cancer (which significantly improves outcomes) or reassurance if benign.

How the biopsy is done

A soft-tissue biopsy is a relatively simple procedure, and understanding it clarifies what's involved.

A soft-tissue biopsy is typically a relatively simple, minor surgical procedure (often done in the office under local anesthesia). The procedure generally involves: anesthesia — numbing the area (local anesthesia); removing the sample — surgically removing a sample of the soft tissue (for an incisional biopsy, a representative portion of the lesion; for an excisional biopsy of a small lesion, the whole lesion), using a scalpel or other instrument, obtaining an intact specimen; managing the site — controlling any bleeding and closing the site (with sutures, if needed, depending on the size); and sending the specimen — placing the sample in a preservative and sending it to the pathology lab with a requisition (the clinical information). So the procedure removes a tissue sample and sends it for analysis.

The procedure is usually quick and done under local anesthesia (an outpatient/in-office procedure), with minimal recovery (the small biopsy site heals). The pathology lab then examines the specimen and provides a report (the diagnosis), typically within some days. For an incisional biopsy (sampling part of a lesion), the diagnosis then guides further treatment (e.g., complete removal if needed, or other management). For an excisional biopsy of a small benign-appearing lesion, removing it may also be the treatment (with the pathology confirming the diagnosis). So the biopsy is a straightforward diagnostic procedure. The dentist/oral surgeon performs the biopsy and sends the specimen. For patients, understanding that a soft-tissue biopsy is a relatively simple procedure — numbing the area, removing a sample, and sending it for analysis — clarifies what's involved. It's a minor procedure. The surgeon performs it. Understanding this helps patients see that a soft-tissue biopsy is typically a relatively simple, minor surgical procedure — numbing the area (local anesthesia), removing a tissue sample (a portion of the lesion, or the whole small lesion), managing the site, and sending the specimen to a pathology lab — usually quick with minimal recovery, with the lab providing the diagnosis (typically within days) that then guides treatment, a straightforward but important diagnostic step.

Biopsy vs cytology, and the related codes

A biopsy differs from cytology sampling, and understanding the related codes clarifies the options.

There are different methods of sampling soft oral tissue for diagnosis, with different codes — and understanding them clarifies the options. D7286 — biopsy of oral tissue, soft: the surgical removal of an intact tissue specimen (a true biopsy — removing a piece of tissue). D7287 — exfoliative cytological sample collection: collecting a cytology sample via mild scraping of the oral mucosa (a non-transepithelial, surface sample — gathering surface cells, not a full tissue piece). D7288 — brush biopsy (transepithelial sample collection): collecting cells via rotational brushing of the mucosa (a transepithelial sample — gathering cells through the thickness of the epithelium using a brush). So D7286 is a surgical biopsy (removing tissue), while D7287 and D7288 are cytology methods (collecting cells by scraping or brushing, without surgically removing a tissue piece).

The distinction: a biopsy (D7286) removes an intact tissue sample (allowing the pathologist to examine the tissue's architecture — generally the definitive diagnostic method), whereas cytology (D7287/D7288) collects cells (a less invasive screening/sampling method, e.g., the brush biopsy as an adjunct to assess a lesion, often followed by a true biopsy if abnormal). So for a definitive diagnosis (especially of a suspicious lesion), a surgical biopsy (D7286) is typically done. The dentist/oral surgeon chooses the appropriate method and codes accordingly. Also, D7286 is not used at the same time as apicoectomy/periradicular curettage codes. So the dentist codes by the sampling method. The dentist uses the appropriate code. For patients, understanding that a biopsy (D7286) differs from cytology sampling (D7287/D7288) clarifies the options. D7286 removes a tissue piece; cytology collects cells. The surgeon chooses the method. Understanding this helps patients see that soft-tissue sampling has different methods/codes — D7286 (a surgical biopsy, removing an intact tissue specimen, the definitive method), D7287 (exfoliative cytology, scraping surface cells), and D7288 (brush biopsy, brushing transepithelial cells) — with the biopsy (D7286) typically used for a definitive diagnosis (especially of suspicious lesions) and cytology as a less invasive sampling/screening method, the dentist coding by the method used.

Frequently asked questions

What is the D7286 dental code?

It's a biopsy of oral tissue — soft — surgically removing a sample of soft oral tissue (gum, mucosa, lip, tongue, etc.) for laboratory (pathology) examination, to diagnose an abnormality (e.g., a suspicious lesion, persistent sore, abnormal patch, or growth). It's for the surgical removal of an intact specimen, typically an incisional biopsy.

What is a soft-tissue biopsy?

A diagnostic procedure removing a sample of soft oral tissue (gum, mucosa, lip, tongue, floor of mouth, etc.) and sending it to a pathology lab for examination (under a microscope) to diagnose an abnormality of those tissues. The ADA description specifies obtaining an architecturally intact specimen.

Why is it done?

To diagnose oral lesions — including the critically important task of evaluating for oral cancer or precancer. Suspicious lesions (persistent sores, abnormal white/red patches, growths) often can't be diagnosed by appearance alone, so a biopsy determines whether they're benign, precancerous (dysplasia), or cancerous — enabling early cancer detection or reassurance.

What does the procedure involve?

Typically a relatively simple, minor procedure — numbing the area (local anesthesia), removing a tissue sample (a portion of the lesion, or a whole small lesion), managing the site (with sutures if needed), and sending the specimen to a pathology lab. It's usually quick with minimal recovery; the lab provides the diagnosis (typically within days).

How much does it cost?

Often around 200 to 500 USD for the surgical removal of the soft-tissue specimen. The pathology lab's examination is a separate cost (the lab fee). The fee reflects the surgical procedure of obtaining the specimen, typically done under local anesthesia.

How is it different from a brush biopsy or cytology?

D7286 is a surgical biopsy (removing an intact tissue specimen — the definitive diagnostic method). D7287 (exfoliative cytology) scrapes surface cells, and D7288 (brush biopsy) brushes transepithelial cells — these collect cells without surgically removing a tissue piece, as less invasive sampling/screening methods. A true biopsy (D7286) is typically used for definitive diagnosis.

This page is an independent, plain-language explanation for general information only. It is not billing, coding, or clinical advice. For the official CDT descriptor and current-year wording, refer to the American Dental Association.